The drug, which has been made in conjunction with AstraZeneca was found to be 90 percent effective once administered with half a dose and then a full dose.
In the data released today, the data also showed there had been no hospitalisations to those who received the drug in trials.
Oxford University and AstraZeneca have also confirmed the date released in the Lancet journal today, has now been passed to the regulators for approval.
Once approved, the UK could have two highly efficient vaccines following the rollout of Pfizer and BioNtech’s drug today.
Health Secretary, Matt Hancock claimed he is hopeful the authorities will grant approval in the coming weeks.
He said today: “We very much hope that it will get approval.
“We hope that to come through in the next couple of weeks.
“It has to be a decision for the independent MHRA, who will only approve it if it is safe to use and effective. So that works underway and I wouldn’t expect anything for the next couple of weeks.”
More to follow…
Published at Tue, 08 Dec 2020 16:19:00 +0000